Crohn's Disease Clinical Trials


A Phase II Efficacy Study in Fistulizing Crohn's Disease Patients

Condition:   Crohn's Disease
Interventions:   Drug: QAX576;   Drug: Infliximab
Sponsor:   Novartis Pharmaceuticals
Completed - verified February 2017

Learn More

A Multi-Center Study to Evaluate the Safety and Efficacy of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatment of Adults With Moderate-to-Severe Crohn's Disease

Condition:   Crohn's Disease
Intervention:   Biological: Human Placenta-Derived Cells PDA001 Intravenous Infusion
Sponsor:   Celgene Corporation
Completed - verified July 2014

Learn More

Effectiveness and Safety in Patients With Crohn´s Disease in Clinical Routine

Condition:   Crohn's Disease
Intervention:  
Sponsor:   AbbVie (prior sponsor, Abbott)
Completed - verified March 2017

Learn More

Contrast Enhanced Ultrasonography (CEUS) of Patients With Crohn's Disease

Condition:   Crohn's Disease
Intervention:  
Sponsors:   Haukeland University Hospital;   University of Bergen;   Abbott
Terminated - verified January 2016

Learn More

Assessment of the Social Cost of Crohn's Disease: Economic and Quality of Life Aspects (Study P04560)

Conditions:   Inflammatory Bowel Disease;   Crohn's Disease
Intervention:   Other: Observational Studies: participants treated according to the real clinical practice.
Sponsor:   Merck Sharp & Dohme Corp.
Completed - verified July 2015

Learn More

Evaluation of a New Oral Contrast Agent for MR Enterography in the Assessment of Crohn Disease in the Small Bowel

Condition:   Crohn Disease
Intervention:  
Sponsor:   Mayo Clinic
Completed - verified January 2016

Learn More

Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease

Condition:   Crohn's Disease
Interventions:   Biological: Adalimumab;   Biological: Adalimumab;   Biological: Adalimumab
Sponsor:   Abbott
Completed - verified July 2011

Learn More

Examining the Long Term Safety, Efficacy, and Corticosteroid-sparing Effect of Certolizumab Pegol in Crohn's Disease

Condition:   Crohn's Disease
Intervention:   Biological: Certolizumab pegol
Sponsor:   UCB Pharma
Completed - verified April 2011

Learn More

16-23 of 23
Results per page

Join the community!


You must be a member of healtheo360 in order to view this group

Register with Email Address

Already a member? Click here to login

healtheo360 believes strongly in user privacy.